4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-048820
Chief Executive Officer sold 4,400 shares at an average $14.67 ($64,526)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ciechanover Isaac E. Chief Executive Officer | 2017-08-10 | Sale | −2,200 | $14.75 | $32,450 | 448,378 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2017-08-11 | Sale | −2,200 | $14.58 | $32,076 | 446,178 | I |
| Open-market sales · 4,400 sh · avg $14.67 · $64,526 | |||||||
Loading xslF345X03/doc4.xml…